Patient Dosing Resumes in Alzheimer’s Clinical Trial
20 Gennaio 2022 - 7:48PM
AllPennyStocks.com
Treatments for Alzheimer’s continue to be lacking in the
clinical community. A drug repurposing by the pharmaceutical
company has the potential to be an effective treatment for mild
to...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Intelgenx Technologies (TSX:IGX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Intelgenx Technologies (TSX:IGX)
Storico
Da Giu 2023 a Giu 2024
